Day: August 25, 2022

Suspension of intra day trading in Denmark with one shareclasses (DKK)

Written by Customer Service on August 25, 2022. Posted in Public Companies.

Lysaker, 25 August 2022 The below share class are suspended from the live trading on Nasdaq Copenhagen until further notice due to missing value. The suspension only affects the below DKK-share class as these are traded intraday on Nasdaq Copenhagen. Share classes and funds by Storebrand Asset Management AS traded at market close in Norway, or any other market, are open for normal trading. For queries, you may contact Storebrand’s Danish branch on +45 33 41 76 53, or Kim.Toftegaard.Andreassen@storebrand.com.Fund name and share class Symbol ISINStorebrand Indeks – Nye Markeder A5 STIINM NO0010841570Regards Storebrand Asset Management AS Kim Toftegaard Andreassen, Director, +45 33 41 76 53 Frode Aasen, Product...

NKT A/S announces expiration date for tender offer regarding securities

Written by Customer Service on August 25, 2022. Posted in Public Companies.

Company Announcement 25 August 2022Announcement No. 18 NOT FOR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES OR TO ANY U.S. PERSON (AS DEFINED IN REGULATION S OF THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED) OR IN ANY JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS DOCUMENT NKT A/S announces expiration date for tender offer regarding securities Reference is made to NKT A/S’ (the “Issuer”) Company Announcement No. 16 of 22 August 2022, according to which the Issuer, in connection with a possible issue of new EUR denominated green subordinated capital securities with an expected issue size of minimum EUR 100,000,000 (the “New Green Subordinated Capital Securities”), is offering holders of the Issuer’s outstanding EUR 150m Callable Subordinated Capital Securities due 3018...

Lauritz.com Group A/S – Interim report January – March 2022

Written by Customer Service on August 25, 2022. Posted in Public Companies.

No. 7/2022 Copenhagen, 25 August 2022 In the first half of 2022 the business of Lauritz.com group delivered EBITDA of DKK 3.4m an improvement of DKK 6.1m compared to last year. The earnings in the first half are positively impacted by cost savings in HQ and owned auction houses, as well as from lower cost due to more auction houses now being owned and due to changes in relation to partner owned houses. Furthermore, the development towards higher yielding business is contributing to the improvement in earnings. During the first part of Q3 Knockdown has been above last year, and we have reduced the decline compared to last year from 4.6 percent in the first half of the year to 1.9 percent year to date by mid-August.Auction Turnover Auction Turnover amounted to DKK 201.5m (211.3), a decrease of 4.6 percent compared to last year. The...

Nexstim Receives an NBS System Order from a Customer in Europe

Written by Customer Service on August 25, 2022. Posted in Public Companies.

Nexstim Receives an NBS System Order from a Customer in Europe Press release, Helsinki, 25 August 2022 at 10 AM (EET) Nexstim Plc (NXTMH:HEX, NXTMS:STO) (“Nexstim” or “Company”) has received an NBS 5 System order from a customer in Europe. The customer is a new user of the Nexstim NBS system, acquiring the system to enable future neuroscience projects. Nexstim’s SmartFocus® nTMS (navigated transcranial magnetic stimulation) technology enables accurate and personalized stimulation, considering the unique shape and conductivity of each patient’s brain. Nexstim’s NBS (Navigated Brain Stimulation) system is used, for example, in planning neurosurgery and in the case of this customer enables neuroscience studies where the stimulation needs to be targeted individually to the brain, reproducing the pulse delivery reliably...

BBS-Bioactive Bone Substitutes Plc: Half-Year Financial Report, 1 January – 30 June 2022 (unaudited)

Written by Customer Service on August 25, 2022. Posted in Public Companies.

BBS-Bioactive Bone Substitutes Plc, Company Announcement, 25 August 2022 at 10.00 (CEST) BBS approaches the CE marking of its first product This release is a summary of BBS-Bioactive Bone Substitutes Plc’s half-yearly report January–June 2022. The entire report is attached to this stock exchange release as a pdf file. The report is also available on BBS-Bioactive Bone Substitutes Plc’s website at https://www.bbs-artebone.fi/. JANUARY-JUNE HIGHLIGHTSArtebone Paste’s CE marking application was submitted to the notified body on March 9, 332022 During the first half-year, BBS-Bioactive Bone Substitutes Plc (BBS) continued to implement the actions required for the registration of the company’s first product (ARTEBONE® Paste) including ramping up production,and preparing for the start of marketing measures. In May – June, the company...

Lauritz.com Group A/S – Interim report January – June 2022 (Correction of Headline only)

Written by Customer Service on August 25, 2022. Posted in Public Companies.

No. 7/2022 Copenhagen, 25 August 2022 In the first half of 2022 the business of Lauritz.com group delivered EBITDA of DKK 3.4m an improvement of DKK 6.1m compared to last year. The earnings in the first half are positively impacted by cost savings in HQ and owned auction houses, as well as from lower cost due to more auction houses now being owned and due to changes in relation to partner owned houses. Furthermore, the development towards higher yielding business is contributing to the improvement in earnings. During the first part of Q3 Knockdown has been above last year, and we have reduced the decline compared to last year from 4.6 percent in the first half of the year to 1.9 percent year to date by mid-August. Auction Turnover Auction Turnover amounted to DKK 201.5m (211.3), a decrease of 4.6 percent compared to last year. The...

NNIT A/S: Management changes in NNIT

Written by Customer Service on August 25, 2022. Posted in Public Companies.

NNIT, a leading provider of IT services and consultancy, is announcing that its current CFO Pernille Fabricius will assume a new role as Executive Vice President for Strategy, Transformation and M&A, and Carsten Ringius will join the Executive Management of NNIT as CFO from December 1, 2022. Since August 2020, Pernille Fabricius has been the CFO of NNIT. In this role, she has taken on a leadership role to transform NNIT. A key deliverable of this transformation has been to divest NNIT’s Infrastructure Operations business (announced June 22, 2022) and to enhance the focus on NNIT’s Life Sciences and Cloud and Digital Solutions business. Given the importance of the ongoing transformation – and shaping two new great companies – Pernille Fabricius will be in charge of Strategy, Transformation, and M&A from December 1, 2022. With...

Infant Bacterial Therapeutics AB (publ) Interim Management Statement January 1-June 30, 2022

Written by Customer Service on August 25, 2022. Posted in Earnings Releases And Operating Results.

Message from the CEO Our IBP-9414 clinical phase III development program is progressing well. We have seen an overall acceleration of recruitment rates and, as mentioned previously, have been working on numerous activities to expedite the execution of our study. It is particularly satisfying to note that the recruitment momentum is picking up at the European hospitals. Today, we have recruited 1,102 children, thus slightly more than half of the children that we will include in the study. During the summer months, we have targeted about 50 children a month and I expect that we will recruit 600 children in total during 2022. Today, the study is open to the smallest children in cohort A (birth weight between 500 grams to 749 grams) as well as the slightly larger children in cohort B (birth weight from 750 grams to 1,000 grams). Once we have...

Saniona publishes its interim report for the second quarter of 2022

Written by Customer Service on August 25, 2022. Posted in Earnings Releases And Operating Results.

Three Months Ended June 30, 2022 (2021) Six Months Ended June 30, 2022 (2021)Revenue was SEK 3.0 M (1.9 M) Revenue was SEK 9.6 M (5.3 M)Operating profit/loss was SEK -91.8 M (-103.6 M)Net profit/loss was SEK -88.6 M (-103.9 M) Operating profit/loss was SEK -225.0 M (-197.7 M)Net profit/loss was SEK -221.9 M (-187.3 M)Basic earnings/loss per share was SEK -1.42 (-1.67) Basic earnings/loss per share was SEK -3.56 (-3.00)Diluted earnings/loss per share were SEK -1.42 (-1.67) Diluted earnings/loss per share were SEK -3.56 (-3.00)Business highlights in Q2 2022On April 30, Saniona appointed Thomas Feldthus as Chief Executive Officer and Anita Milland as Chief Financial Officer. Thomas Feldthus will oversee Saniona’s refocused strategy on ion channel research and development and explore partnering opportunities to advance...

INTERIM REPORT FOR Q3 2021/22

Written by Customer Service on August 25, 2022. Posted in Earnings Releases And Operating Results.

Ambu delivered 8% organic revenue growth in Q3 with 5% organic growth year-to-date. This was driven by a continued rapid uptake of Ambu’s single-use endoscopes within urology and ENT, as well as pent-up demand for Anaesthesia and Patient Monitoring & Diagnostics (PMD) products. The financial outlook from 3 August, 2022 is maintained. Britt Meelby Jensen, Chief Executive Officer of Ambu, says:“For Q3, I am happy to see that we continued to deliver rapid growth in our urology and ENT businesses, which are segments that we have entered in recent years. We also saw strong performance for Anaesthesia and PMD. Bronchoscopy was impacted negatively by lower ICU admissions and Covid-19-related inventory as well as a high baseline. However, I am excited about the opportunities in the bronchoscopy market with approval of our new advanced bronchoscopy...

Day: August 25, 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals